id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0090-0275,FDA,FDA-2011-N-0090,FDA/OC to Dockets Management - Memorandum,Other,Memorandum,2013-10-24T04:00:00Z,2013,10,2013-10-24T04:00:00Z,,2013-10-24T15:45:52Z,,0,0,090000648145cdfb
FDA-2011-N-0090-0274,FDA,FDA-2011-N-0090,Unique Device Identification System,Rule,Final Rule,2013-09-24T04:00:00Z,2013,9,2013-09-24T04:00:00Z,,2013-09-26T13:15:30Z,2013-23059,0,0,09000064814340dc
FDA-2011-N-0090-0273,FDA,FDA-2011-N-0090,Alphatec Spine - Supplement,Supporting & Related Material,Supplement,2013-02-01T05:00:00Z,2013,2,,,2013-02-01T20:18:14Z,,0,0,09000064811df0d0